KIMIA BIOSCIENCES
|
KIMIA BIOSCIENCES Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 1.57 | 2.03 | -1.12 | -1.98 | -0.78 |
| CEPS(Rs) | 2.40 | 2.75 | -0.43 | -1.27 | -0.16 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 3.75 | 2.11 | 0.07 | 1.15 | 3.15 |
| Tax Rate(%) | 12.13 | 29.50 | 26.10 | 24.51 | 26.21 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.42 | 17.03 | -0.46 | -3.96 | 0.51 |
| EBIT Margin(%) | 10.42 | 15.30 | -2.03 | -6.34 | -1.10 |
| Pre Tax Margin(%) | 7.36 | 11.46 | -6.85 | -9.64 | -4.02 |
| PAT Margin (%) | 6.47 | 8.08 | -5.06 | -7.28 | -2.96 |
| Cash Profit Margin (%) | 9.88 | 10.92 | -1.92 | -4.68 | -0.61 |
| Performance Ratios | |||||
| ROA(%) | 7.01 | 9.44 | -5.02 | -8.28 | -3.44 |
| ROE(%) | 53.70 | 186.70 | -183.25 | -91.91 | -22.22 |
| ROCE(%) | 25.24 | 42.18 | -4.18 | -14.30 | -2.32 |
| Asset Turnover(x) | 1.08 | 1.17 | 0.99 | 1.14 | 1.16 |
| Sales/Fixed Asset(x) | 2.05 | 2.39 | 2.25 | 2.85 | 3.18 |
| Working Capital/Sales(x) | 47.15 | -18.20 | -13.06 | 20.24 | 11.08 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.49 | 0.42 | 0.45 | 0.35 | 0.31 |
| Receivable days | 104.96 | 98.68 | 101.18 | 86.33 | 105.16 |
| Inventory Days | 96.65 | 100.34 | 137.54 | 121.06 | 88.70 |
| Payable days | 241.28 | 233.00 | 209.95 | 164.94 | 140.43 |
| Valuation Parameters | |||||
| PER(x) | 14.99 | 20.92 | - | - | - |
| PCE(x) | 9.82 | 15.48 | -130.77 | -25.54 | -233.46 |
| Price/Book(x) | 6.29 | 20.18 | 796.60 | 28.15 | 11.95 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.26 | 1.96 | 2.92 | 1.60 | 1.75 |
| EV/Core EBITDA(x) | 9.14 | 10.80 | 264.63 | -54.80 | 139.42 |
| EV/EBIT(x) | 12.13 | 12.81 | -143.65 | -25.32 | -158.27 |
| EV/CE(x) | 2.77 | 5.48 | 7.01 | 3.53 | 3.93 |
| M Cap / Sales | 0.97 | 1.69 | 2.51 | 1.20 | 1.42 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -3.39 | 13.39 | -18.39 | 2.89 | -5.89 |
| Core EBITDA Growth(%) | -26.34 | 1,762.06 | 130.79 | -340.65 | -85.57 |
| EBIT Growth(%) | -34.17 | 952.49 | 73.79 | -491.19 | -115.43 |
| PAT Growth(%) | -22.67 | 281.07 | 43.24 | -152.56 | -172.55 |
| EPS Growth(%) | -22.66 | 281.07 | 43.24 | -152.55 | -172.55 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.95 | 3.27 | 131.12 | 9.69 | 2.73 |
| Current Ratio(x) | 1.04 | 0.92 | 0.88 | 1.08 | 1.18 |
| Quick Ratio(x) | 0.61 | 0.50 | 0.44 | 0.45 | 0.58 |
| Interest Cover(x) | 3.41 | 3.99 | -0.42 | -1.92 | -0.38 |
| Total Debt/Mcap(x) | 0.31 | 0.16 | 0.16 | 0.34 | 0.23 |
Compare Financial Ratios of peers of KIMIA BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KIMIA BIOSCIENCES | ₹158.4 Cr | 11.3% | -0.2% | 7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | 11.3% |
-0.2% |
7.8% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses